Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial
CHEST Pulmonary
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “General Medicine”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial. // CHEST Pulmonary. – URL: https://www.sciencedirect.com/science/article/pii/S2949789226000619?dgcid=rss_sd_all
Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial. CHEST Pulmonary. https://www.sciencedirect.com/science/article/pii/S2949789226000619?dgcid=rss_sd_all
“Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial.” CHEST Pulmonary.
@article{article93470,
title = {Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
journal = {CHEST Pulmonary},
url = {https://www.sciencedirect.com/science/article/pii/S2949789226000619?dgcid=rss_sd_all}
}